Kyntra Bio Other Long Term Assets (Quarterly) Analysis

Kyntra Bio, Inc. (KYNB)

8.55 -0.59 (-6.46%) USD | NASDAQ | Jan 20, 16:00

8.59 +0.04 (+0.47%) Pre-Market: 20:00

View Other Long Term Assets (Quarterly) for KYNB.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Assets (Quarterly) Benchmarks

Start Trial

Assertio Holdings, Inc.	--
Perspective Therapeutics, Inc.	Upgrade
Skye Bioscience, Inc.	Upgrade
Theravance Biopharma, Inc.	Upgrade
Myomo, Inc.	Upgrade